Re: Resverlogix’ BETonMACE Phase 3 Trial Successfully Reaches its Targeted 250 MACE Events
|
2
|
Resverlogix Corp.
|
Apr 18, 2019 08:28AM
|
Re: Resverlogix’s BETonMACE Phase 3 Epigenetics Trial Completes Final Safety Visits
|
3
|
Resverlogix Corp.
|
Jul 08, 2019 04:27PM
|
Re: Resverlogix’s BETonMACE Phase 3 Epigenetics Trial Completes Final Safety Visits
|
2
|
Resverlogix Corp.
|
Jul 08, 2019 09:11AM
|
Re: Resverlogix’s BETonMACE Phase 3 Epigenetics Trial Completes Final Safety Visits
|
|
Resverlogix Corp.
|
Jul 08, 2019 12:49PM
|
Re: Revamped website
|
11
|
Resverlogix Corp.
|
Jan 05, 2019 06:09PM
|
Re: Revamped website
|
5
|
Resverlogix Corp.
|
Jan 05, 2019 08:30PM
|
Re: Rhino Corporate Communications.....
|
2
|
Resverlogix Corp.
|
Feb 04, 2020 12:15PM
|
Re: Righting the (underpowered) vessel
|
3
|
Resverlogix Corp.
|
Oct 31, 2019 04:57PM
|
Re: Righting the (underpowered) vessel
|
3
|
Resverlogix Corp.
|
Oct 31, 2019 05:00PM
|
Re: rndbtl on IV - Sanofi's relationship with Rothschild
|
2
|
Resverlogix Corp.
|
Jan 14, 2019 04:21PM
|
Re: rndbtl on IV - Sanofi's relationship with Rothschild
|
1
|
Resverlogix Corp.
|
Jan 14, 2019 06:18PM
|
Re: rndbtl on IV - Sanofi's relationship with Rothschild
|
2
|
Resverlogix Corp.
|
Jan 14, 2019 06:35PM
|
Re: rndtbl has posted some very interesting PAH study slides using RVX-208 on the other board
|
3
|
Resverlogix Corp.
|
Dec 05, 2019 09:49AM
|
Re: rndtbl has posted some very interesting PAH study slides using RVX-208 on the other board
|
1
|
Resverlogix Corp.
|
Dec 05, 2019 11:30AM
|
Re: Roth Conference March 19th 11:00 AM Fireside Chat
|
|
Resverlogix Corp.
|
Mar 15, 2019 02:51PM
|
Re: Roth Conference March 19th 11:00 AM Fireside Chat
|
2
|
Resverlogix Corp.
|
Mar 09, 2019 08:43AM
|
Re: RRR %
|
1
|
Resverlogix Corp.
|
Jul 01, 2019 09:32AM
|
Re: RRR %
|
1
|
Resverlogix Corp.
|
Jul 01, 2019 12:42PM
|
Re: Rules of thumb and broken thumbs...
|
2
|
Resverlogix Corp.
|
Sep 29, 2020 12:12PM
|
Re: RVX AGM Q&A, post AGM-huddle, impressions
|
5
|
Resverlogix Corp.
|
Sep 19, 2018 08:47AM
|